Literature DB >> 9577281

Modulation by magnesium of N-methyl-D-aspartate receptors in developing human brain.

H Chahal1, S W D'Souza, A J Barson, P Slater.   

Abstract

AIM: To investigate age related alterations in glutamate N-methyl-D-aspartate (NMDA) receptor binding produced by the modulatory compounds glutamate, glycine, and magnesium (Mg2+) sulphate.
METHODS: The effects produced by glutamate plus glycine, and Mg2+ on the binding of [3H]MK-801, a ligand for the N-methyl-D-aspartate ion channel phencyclidine site, were measured in membrane preparations made from prefrontal cortex from human neonate (n = 5), infant (n = 6), and adult (n = 6) necropsy brains.
RESULTS: Neonatal brains had the least [3H]MK-801 binding, suggesting either a low density of NMDA receptors or a more restricted access of [3H]MK-801 to cation channel sites. Infant brains had the most [3H]MK-801 binding which was stimulated to a greater extent by L-glutamate (100 microM) and glycine (10 microM) than in neonatal and adult brains. MG2+ invariably inhibited [3H]MK-801 binding. However, the Mg2+ IC50 value was higher in neonatal brain (3.6 mM) than infant (1.4 mM) and adult (0.87 mM) brains.
CONCLUSION: Infant brain may have excess NMDA receptors which are hyper responsive to glutamate and glycine. The lower potency of Mg2+ to inhibit [3H]MK-801 binding in neonatal cortex may be because newborn babies have NMDA receptors without the normal complement of Mg2+ sites. The findings suggest that therapeutic NMDA receptor block in neonates requires higher concentrations of magnesium sulphate in brain tissue.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9577281      PMCID: PMC1720765          DOI: 10.1136/fn.78.2.f116

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  42 in total

1.  Developmental and regional expression in the rat brain and functional properties of four NMDA receptors.

Authors:  H Monyer; N Burnashev; D J Laurie; B Sakmann; P H Seeburg
Journal:  Neuron       Date:  1994-03       Impact factor: 17.173

2.  Treatment with NMDA receptor antagonists does not affect developmental changes in NMDA receptor properties in vivo.

Authors:  M Van Lookeren Campagne; J P Vermeulen; G J Boer; R Balázs
Journal:  Neurochem Int       Date:  1995 Oct-Nov       Impact factor: 3.921

3.  Kinetics and Mg2+ block of N-methyl-D-aspartate receptor channels during postnatal development of hippocampal CA3 pyramidal neurons.

Authors:  R Khazipov; D Ragozzino; P Bregestovski
Journal:  Neuroscience       Date:  1995-12       Impact factor: 3.590

4.  Multiple structural elements determine subunit specificity of Mg2+ block in NMDA receptor channels.

Authors:  T Kuner; R Schoepfer
Journal:  J Neurosci       Date:  1996-06-01       Impact factor: 6.167

5.  Glycine-independent and subunit-specific potentiation of NMDA responses by extracellular Mg2+.

Authors:  P Paoletti; J Neyton; P Ascher
Journal:  Neuron       Date:  1995-11       Impact factor: 17.173

6.  Blockade of NMDA-activated channels by magnesium in the immature rat hippocampus.

Authors:  G J Strecker; M B Jackson; F E Dudek
Journal:  J Neurophysiol       Date:  1994-10       Impact factor: 2.714

7.  Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?

Authors:  K B Nelson; J K Grether
Journal:  Pediatrics       Date:  1995-02       Impact factor: 7.124

8.  Polyamines antagonize N-methyl-D-aspartate-evoked depolarizations, but reduce Mg2+ block.

Authors:  M A Bowe; J V Nadler
Journal:  Eur J Pharmacol       Date:  1995-05-04       Impact factor: 4.432

9.  Identification of a high affinity divalent cation binding site near the entrance of the NMDA receptor channel.

Authors:  L S Premkumar; A Auerbach
Journal:  Neuron       Date:  1996-04       Impact factor: 17.173

10.  Prevention by magnesium of excitotoxic neuronal death in the developing brain: an animal model for clinical intervention studies.

Authors:  S Marret; P Gressens; J F Gadisseux; P Evrard
Journal:  Dev Med Child Neurol       Date:  1995-06       Impact factor: 5.449

View more
  6 in total

1.  Altered development of glutamatergic synapses in layer V pyramidal neurons in NR3A knockout mice.

Authors:  Chengwen Zhou; Frances E Jensen; Nikolaus J Sucher
Journal:  Mol Cell Neurosci       Date:  2009-09-24       Impact factor: 4.314

2.  Association of umbilical cord blood lead with neonatal behavior at varying levels of exposure.

Authors:  Archana B Patel; Manju R Mamtani; Tushar P Thakre; Hemant Kulkarni
Journal:  Behav Brain Funct       Date:  2006-06-27       Impact factor: 3.759

3.  Expression of Circ_Satb1 Is Decreased in Mesial Temporal Lobe Epilepsy and Regulates Dendritic Spine Morphology.

Authors:  Andreia Gomes-Duarte; Morten T Venø; Marina de Wit; Ketharini Senthilkumar; Mark H Broekhoven; Joëlle van den Herik; Fleur R Heeres; Daniëlle van Rossum; Mateja Rybiczka-Tesulov; Ivano Legnini; Peter C van Rijen; Pieter van Eijsden; Peter H Gosselaar; Nikolaus Rajewsky; Jørgen Kjems; Vamshidhar R Vangoor; R Jeroen Pasterkamp
Journal:  Front Mol Neurosci       Date:  2022-03-03       Impact factor: 5.639

4.  Opioid analgesia in mechanically ventilated children: results from the multicenter Measuring Opioid Tolerance Induced by Fentanyl study.

Authors:  Kanwaljeet J S Anand; Amy E Clark; Douglas F Willson; John Berger; Kathleen L Meert; Jerry J Zimmerman; Rick Harrison; Joseph A Carcillo; Christopher J L Newth; Stephanie Bisping; Richard Holubkov; J Michael Dean; Carol E Nicholson
Journal:  Pediatr Crit Care Med       Date:  2013-01       Impact factor: 3.624

5.  Ketamine analgesia for inflammatory pain in neonatal rats: a factorial randomized trial examining long-term effects.

Authors:  Cynthia R Rovnaghi; Sarita Garg; Richard W Hall; Adnan T Bhutta; K Js Anand
Journal:  Behav Brain Funct       Date:  2008-08-07       Impact factor: 3.759

Review 6.  Multifactorial determinants of cognition - Thyroid function is not the only one.

Authors:  Roy Moncayo; Karina Ortner
Journal:  BBA Clin       Date:  2015-04-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.